{
  "DOI": "10.1186/s40246-023-00545-w",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00545-w",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eAlternative splicing (AS) plays a crucial role in transcriptomic diversity and is a hallmark of cancer that profoundly influences the development and progression of prostate cancer (PCa), a prevalent and potentially life-limiting cancer among men. Accumulating evidence has highlighted the association between AS dysregulation and the onset and progression of PCa. However, a comprehensive and integrative analysis of AS profiles at the event level, utilising data from multiple high-throughput cohorts and evaluating the prognosis of PCa progression, remains lacking and calls for thorough exploration.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe identified a differentially expressed retained intron event in \u003cjats:italic\u003eZWINT\u003c/jats:italic\u003e across three distinct cohorts, encompassing an original array-based dataset profiled by us previously and two RNA sequencing (RNA-seq) datasets. Subsequent in-depth analyses of these RNA-seq datasets revealed  141 altered events, of which 21 demonstrated a significant association with patients’ biochemical recurrence-free survival (BCRFS). We formulated an AS event-based prognostic signature, capturing six pivotal events in genes \u003cjats:italic\u003eCYP4F12\u003c/jats:italic\u003e, \u003cjats:italic\u003eNFATC4\u003c/jats:italic\u003e, \u003cjats:italic\u003ePIGO\u003c/jats:italic\u003e, \u003cjats:italic\u003eCYP3A5\u003c/jats:italic\u003e, \u003cjats:italic\u003eALS2CL\u003c/jats:italic\u003e, and \u003cjats:italic\u003eFXYD3\u003c/jats:italic\u003e. This signature effectively differentiated  high-risk patients diagnosed with PCa, who experienced shorter BCRFS, from their low-risk counterparts. Notably, the signature's predictive power surpassed traditional clinicopathological markers in forecasting 5-year BCRFS, demonstrating robust performance in both internal and external validation sets. Lastly, we constructed a novel nomogram that integrates patients’ Gleason scores with pathological tumour stages, demonstrating improved prognostication of BCRFS.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003ePrediction of clinical progression remains elusive in PCa. This research uncovers novel splicing events associated with BCRFS, augmenting existing prognostic tools, thus potentially refining clinical decision-making.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "545"
  ],
  "article-number": "97",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "6 September 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "20 October 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "3 November 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "LWH is founder, director and chief scientific officer of SENISCA Ltd. SENISCA’s commercial activities have no bearing on the content of this publication."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Mou",
      "given": "Zhuofan",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Spencer",
      "given": "Jack",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "McGrath",
      "given": "John S.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Harries",
      "given": "Lorna W.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        11,
        3
      ]
    ],
    "date-time": "2023-11-03T10:02:35Z",
    "timestamp": 1699005755000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        3
      ]
    ],
    "date-time": "2023-11-03T10:08:42Z",
    "timestamp": 1699006122000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        26
      ]
    ],
    "date-time": "2024-04-26T05:08:31Z",
    "timestamp": 1714108111231
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        11,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            3
          ]
        ],
        "date-time": "2023-11-03T00:00:00Z",
        "timestamp": 1698969600000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            11,
            3
          ]
        ],
        "date-time": "2023-11-03T00:00:00Z",
        "timestamp": 1698969600000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00545-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00545-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00545-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        11,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        11,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "545_CR1",
      "unstructured": "Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F, Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. Available from: https://gco.iarc.fr/today/home."
    },
    {
      "key": "545_CR2",
      "unstructured": "National Cancer Institute. Cancer Stat Facts: Prostate Cancer 2021. Available from: https://seer.cancer.gov/statfacts/html/prost.html."
    },
    {
      "DOI": "10.1038/nrg2776",
      "author": "H Keren",
      "doi-asserted-by": "publisher",
      "first-page": "345",
      "issue": "5",
      "journal-title": "Nat Rev Genet",
      "key": "545_CR3",
      "unstructured": "Keren H, Lev-Maor G, Ast G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet. 2010;11(5):345–55.",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41571-018-0085-0",
      "author": "A Paschalis",
      "doi-asserted-by": "publisher",
      "first-page": "663",
      "issue": "11",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "545_CR4",
      "unstructured": "Paschalis A, Sharp A, Welti JC, Neeb A, Raj GV, Luo J, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15(11):663–75.",
      "volume": "15",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41467-020-15815-7",
      "author": "D Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2089",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "545_CR5",
      "unstructured": "Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, et al. Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer. Nat Commun. 2020;11(1):2089.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ebiom.2019.11.008",
      "author": "JM Jiménez-Vacas",
      "doi-asserted-by": "publisher",
      "first-page": "102547",
      "journal-title": "EBioMedicine",
      "key": "545_CR6",
      "unstructured": "Jiménez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gómez-Gómez E, Fuentes-Fayos AC, León-González AJ, et al. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. 2020;51:102547.",
      "volume": "51",
      "year": "2020"
    },
    {
      "DOI": "10.3390/genes12091457",
      "author": "E Hasimbegovic",
      "doi-asserted-by": "publisher",
      "first-page": "1457",
      "issue": "9",
      "journal-title": "Genes (Basel).",
      "key": "545_CR7",
      "unstructured": "Hasimbegovic E, Schweiger V, Kastner N, Spannbauer A, Traxler D, Lukovic D, et al. Alternative splicing in cardiovascular disease: a survey of recent findings. Genes (Basel). 2021;12(9):1457.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.neuron.2006.09.017",
      "author": "DD Licatalosi",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "issue": "1",
      "journal-title": "Neuron",
      "key": "545_CR8",
      "unstructured": "Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron. 2006;52(1):93–101.",
      "volume": "52",
      "year": "2006"
    },
    {
      "DOI": "10.1186/s40035-021-00240-7",
      "author": "D Li",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "issue": "1",
      "journal-title": "Transl Neurodegener",
      "key": "545_CR9",
      "unstructured": "Li D, McIntosh CS, Mastaglia FL, Wilton SD, Aung-Htut MT. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. Transl Neurodegener. 2021;10(1):16.",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.1038/onc.2015.318",
      "author": "A Sveen",
      "doi-asserted-by": "publisher",
      "first-page": "2413",
      "issue": "19",
      "journal-title": "Oncogene",
      "key": "545_CR10",
      "unstructured": "Sveen A, Kilpinen S, Ruusulehto A, Lothe RA, Skotheim RI. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene. 2016;35(19):2413–27.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1155/2013/703568",
      "author": "J-Y Tang",
      "doi-asserted-by": "publisher",
      "first-page": "703568",
      "journal-title": "Sci World J.",
      "key": "545_CR11",
      "unstructured": "Tang J-Y, Lee J-C, Hou M-F, Wang C-L, Chen C-C, Huang H-W, Chang H-W. Alternative splicing for diseases, cancers, drugs, and databases. Sci World J. 2013;2013:703568. https://doi.org/10.1155/2013/703568.",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.semcdb.2017.09.018",
      "author": "X Song",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Semin Cell Dev Biol",
      "key": "545_CR12",
      "unstructured": "Song X, Zeng Z, Wei H, Wang Z. Alternative splicing in cancers: From aberrant regulation to new therapeutics. Semin Cell Dev Biol. 2018;75:13–22.",
      "volume": "75",
      "year": "2018"
    },
    {
      "DOI": "10.1155/2013/463786",
      "author": "M Ladomery",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Cell Biol",
      "key": "545_CR13",
      "unstructured": "Ladomery M. Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol. 2013;2013: 463786.",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1111/cas.14525",
      "author": "J Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "3020",
      "issue": "8",
      "journal-title": "Cancer Sci",
      "key": "545_CR14",
      "unstructured": "Zhao J, Chang L, Gu X, Liu J, Sun B, Wei X. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer. Cancer Sci. 2020;111(8):3020–31.",
      "volume": "111",
      "year": "2020"
    },
    {
      "DOI": "10.21037/tau-21-585",
      "author": "T Wu",
      "doi-asserted-by": "publisher",
      "first-page": "3056",
      "issue": "7",
      "journal-title": "Transl Androl Urol",
      "key": "545_CR15",
      "unstructured": "Wu T, Wang W, Wang Y, Yao M, Du L, Zhang X, et al. Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer. Transl Androl Urol. 2021;10(7):3056–68.",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.7150/jca.31725",
      "author": "ZX Cao",
      "doi-asserted-by": "publisher",
      "first-page": "5585",
      "issue": "22",
      "journal-title": "J Cancer",
      "key": "545_CR16",
      "unstructured": "Cao ZX, Xiao GA, Zhang W, Ji J, Ye C, Liu D, et al. Comprehensive investigation of alternative splicing and development of a prognostic risk score for prostate cancer based on six-gene signatures. J Cancer. 2019;10(22):5585–96.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ng.259",
      "author": "Q Pan",
      "doi-asserted-by": "publisher",
      "first-page": "1413",
      "issue": "12",
      "journal-title": "Nat Genet",
      "key": "545_CR17",
      "unstructured": "Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413–5.",
      "volume": "40",
      "year": "2008"
    },
    {
      "DOI": "10.1093/bib/bbz126",
      "author": "A Mehmood",
      "doi-asserted-by": "publisher",
      "first-page": "2052",
      "issue": "6",
      "journal-title": "Brief Bioinform",
      "key": "545_CR18",
      "unstructured": "Mehmood A, Laiho A, Venäläinen MS, McGlinchey AJ, Wang N, Elo LL. Systematic evaluation of differential splicing tools for RNA-seq studies. Brief Bioinform. 2020;21(6):2052–65.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.1419161111",
      "author": "S Shen",
      "doi-asserted-by": "publisher",
      "first-page": "E5593",
      "issue": "51",
      "journal-title": "Proc Natl Acad Sci",
      "key": "545_CR19",
      "unstructured": "Shen S, Park JW, Lu Z, Lin L, Henry MD, Wu YN, et al. rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci. 2014;111(51):E5593–601.",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1093/nar/gkv1288",
      "author": "M Ryan",
      "doi-asserted-by": "publisher",
      "first-page": "D1018",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "545_CR20",
      "unstructured": "Ryan M, Wong WC, Brown R, Akbani R, Su X, Broom B, et al. TCGASpliceSeq a compendium of alternative mRNA splicing in cancer. Nucleic Acids Res. 2016;44(D1):D1018–22.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s12864-016-2816-x",
      "author": "JP Romero",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "1",
      "journal-title": "BMC Genomics",
      "key": "545_CR21",
      "unstructured": "Romero JP, Muniategui A, De Miguel FJ, Aramburu A, Montuenga L, Pio R, et al. EventPointer: an effective identification of alternative splicing events using junction arrays. BMC Genomics. 2016;17(1):467.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.3389/fonc.2022.914078",
      "author": "Z Mou",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Oncol",
      "key": "545_CR22",
      "unstructured": "Mou Z, Spencer J, Knight B, John J, McCullagh P, McGrath JS, et al. Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer. Front Oncol. 2022;12: 914078.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1056/NEJMp1607591",
      "author": "RL Grossman",
      "doi-asserted-by": "publisher",
      "first-page": "1109",
      "issue": "12",
      "journal-title": "N Engl J Med",
      "key": "545_CR23",
      "unstructured": "Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375(12):1109–12.",
      "volume": "375",
      "year": "2016"
    },
    {
      "DOI": "10.1093/nar/gkv1507",
      "author": "A Colaprico",
      "doi-asserted-by": "publisher",
      "first-page": "e71",
      "issue": "8",
      "journal-title": "Nucleic Acids Res",
      "key": "545_CR24",
      "unstructured": "Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2015;44(8):e71.",
      "volume": "44",
      "year": "2015"
    },
    {
      "DOI": "10.1038/cr.2012.30",
      "author": "S Ren",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "issue": "5",
      "journal-title": "Cell Res",
      "key": "545_CR25",
      "unstructured": "Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res. 2012;22(5):806–21.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1093/nar/gkq967",
      "author": "R Leinonen",
      "doi-asserted-by": "publisher",
      "first-page": "D28",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "545_CR26",
      "unstructured": "Leinonen R, Akhtar R, Birney E, Bower L, Cerdeno-Tárraga A, Cheng Y, et al. The European nucleotide archive. Nucleic Acids Res. 2011;39(Database issue):D28-31.",
      "volume": "39",
      "year": "2011"
    },
    {
      "key": "545_CR27",
      "unstructured": "Petit III, RA, Hall MB, Tonkin-Hill G, Zhu J, Read TD. fastq-dl: efficiently download FASTQ files from SRA or ENA repositories (Version 2.0.2) [Computer software]. https://github.com/rpetit3/fastq-dl."
    },
    {
      "DOI": "10.1016/j.ccell.2019.02.005",
      "author": "A Sinha",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "issue": "3",
      "journal-title": "Cancer Cell",
      "key": "545_CR28",
      "unstructured": "Sinha A, Huang V, Livingstone J, Wang J, Fox NS, Kurganovs N, et al. The proteogenomic landscape of curable prostate cancer. Cancer Cell. 2019;35(3):414-27.e6.",
      "volume": "35",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/30.1.207",
      "author": "R Edgar",
      "doi-asserted-by": "publisher",
      "first-page": "207",
      "issue": "1",
      "journal-title": "Nucleic Acids Res",
      "key": "545_CR29",
      "unstructured": "Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–10.",
      "volume": "30",
      "year": "2002"
    },
    {
      "key": "545_CR30",
      "unstructured": "Bengtsson H, Simpson KM, Bullard JH, Hansen KD, editors. aroma.affymetrix: a generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory. 2008. Available online: https://statistics.berkeley.edu/sites/default/files/tech-reports/745.pdf."
    },
    {
      "DOI": "10.1038/s41592-019-0422-y",
      "author": "J Lever",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "issue": "6",
      "journal-title": "Nat Methods",
      "key": "545_CR31",
      "unstructured": "Lever J, Zhao EY, Grewal J, Jones MR, Jones SJM. CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer. Nat Methods. 2019;16(6):505–7.",
      "volume": "16",
      "year": "2019"
    },
    {
      "DOI": "10.1093/bioinformatics/btp616",
      "author": "MD Robinson",
      "doi-asserted-by": "publisher",
      "first-page": "139",
      "issue": "1",
      "journal-title": "Bioinformatics",
      "key": "545_CR32",
      "unstructured": "Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1093/nar/gkv007",
      "author": "ME Ritchie",
      "doi-asserted-by": "publisher",
      "first-page": "e47",
      "issue": "7",
      "journal-title": "Nucleic Acids Res",
      "key": "545_CR33",
      "unstructured": "Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1186/gb-2014-15-2-r29",
      "author": "CW Law",
      "doi-asserted-by": "publisher",
      "first-page": "R29",
      "issue": "2",
      "journal-title": "Genome Biol",
      "key": "545_CR34",
      "unstructured": "Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.",
      "volume": "15",
      "year": "2014"
    },
    {
      "key": "545_CR35",
      "unstructured": "Andrews   S. FastQC: a quality control tool for high throughput sequence data. http://www.BioinformaticsBabrahamAcUk/Projects/Fastqc/2010; http://www.bioinformatics.babraham.ac.uk/projects/."
    },
    {
      "DOI": "10.1093/bioinformatics/btw354",
      "author": "P Ewels",
      "doi-asserted-by": "publisher",
      "first-page": "3047",
      "issue": "19",
      "journal-title": "Bioinformatics",
      "key": "545_CR36",
      "unstructured": "Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047–8.",
      "volume": "32",
      "year": "2016"
    },
    {
      "key": "545_CR37",
      "unstructured": "Andrews S. Babraham bioinformatics—trim Galore! Trim Galore! wrapper script for automated quality and adapter trimming and quality control. https://github.com/FelixKrueger/TrimGalore."
    },
    {
      "DOI": "10.1093/bioinformatics/bts635",
      "author": "A Dobin",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "issue": "1",
      "journal-title": "Bioinformatics",
      "key": "545_CR38",
      "unstructured": "Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.",
      "volume": "29",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.21609",
      "author": "F Piva",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "issue": "1",
      "journal-title": "Hum Mutat",
      "key": "545_CR39",
      "unstructured": "Piva F, Giulietti M, Burini AB, Principato G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum Mutat. 2012;33(1):81–5.",
      "volume": "33",
      "year": "2012"
    },
    {
      "DOI": "10.18637/jss.v033.i01",
      "author": "J Friedman",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "J Stat Softw",
      "key": "545_CR40",
      "unstructured": "Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.",
      "volume": "33",
      "year": "2010"
    },
    {
      "key": "545_CR41",
      "unstructured": "Therneau T. A Package for Survival Analysis in R. R package version 3.4-0. 2022. https://CRAN.R-project.org/package=survival."
    },
    {
      "key": "545_CR42",
      "unstructured": "Kassambara A, Kosinski M, Biecek P. Survminer: Drawing survival curves using ggplot2. R package version 0.4.9. 2021. https://CRAN.R-project.org/package=survminer."
    },
    {
      "key": "545_CR43",
      "unstructured": "Heagerty PJ. By paramita saha-chaudhuri p. survivalROC: Time-dependent ROC curve estimation from censored survival data. R package version 1.0.3.1. 2022.  https://CRAN.R-project.org/package=survivalROC."
    },
    {
      "DOI": "10.3390/ijms19051287",
      "author": "E Antonopoulou",
      "doi-asserted-by": "publisher",
      "first-page": "1287",
      "issue": "5",
      "journal-title": "Int J Mol Sci",
      "key": "545_CR44",
      "unstructured": "Antonopoulou E, Ladomery M. Targeting splicing in prostate cancer. Int J Mol Sci. 2018;19(5):1287.",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1042/BST20120026",
      "author": "RM Hagen",
      "doi-asserted-by": "publisher",
      "first-page": "870",
      "issue": "4",
      "journal-title": "Biochem Soc Trans",
      "key": "545_CR45",
      "unstructured": "Hagen RM, Ladomery MR. Role of splice variants in the metastatic progression of prostate cancer. Biochem Soc Trans. 2012;40(4):870–4.",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.18632/oncotarget.1802",
      "author": "B Cao",
      "doi-asserted-by": "publisher",
      "first-page": "1646",
      "issue": "6",
      "journal-title": "Oncotarget",
      "key": "545_CR46",
      "unstructured": "Cao B, Qi Y, Zhang G, Xu D, Zhan Y, Alvarez X, et al. Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget. 2014;5(6):1646–56.",
      "volume": "5",
      "year": "2014"
    },
    {
      "DOI": "10.1038/onc.2013.284",
      "author": "LL Liu",
      "doi-asserted-by": "publisher",
      "first-page": "3140",
      "issue": "24",
      "journal-title": "Oncogene",
      "key": "545_CR47",
      "unstructured": "Liu LL, Xie N, Sun S, Plymate S, Mostaghel E, Dong X. Mechanisms of the androgen receptor splicing in prostate cancer cells. Oncogene. 2014;33(24):3140–50.",
      "volume": "33",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0019059",
      "author": "E Hörnberg",
      "doi-asserted-by": "publisher",
      "issue": "4",
      "journal-title": "PLoS ONE",
      "key": "545_CR48",
      "unstructured": "Hörnberg E, Ylitalo EB, Crnalic S, Antti H, Stattin P, Widmark A, et al. Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival. PLoS ONE. 2011;6(4): e19059.",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1001/jamaoncol.2016.1828",
      "author": "HI Scher",
      "doi-asserted-by": "publisher",
      "first-page": "1441",
      "issue": "11",
      "journal-title": "JAMA Oncol",
      "key": "545_CR49",
      "unstructured": "Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, et al. Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA Oncol. 2016;2(11):1441–9.",
      "volume": "2",
      "year": "2016"
    },
    {
      "DOI": "10.1172/JCI41824",
      "author": "S Sun",
      "doi-asserted-by": "publisher",
      "first-page": "2715",
      "issue": "8",
      "journal-title": "J Clin Invest",
      "key": "545_CR50",
      "unstructured": "Sun S, Sprenger CC, Vessella RL, Haugk K, Soriano K, Mostaghel EA, et al. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J Clin Invest. 2010;120(8):2715–30.",
      "volume": "120",
      "year": "2010"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-04-0934",
      "author": "J Woolard",
      "doi-asserted-by": "publisher",
      "first-page": "7822",
      "issue": "21",
      "journal-title": "Cancer Res",
      "key": "545_CR51",
      "unstructured": "Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO, et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 2004;64(21):7822–35.",
      "volume": "64",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.bjc.6604309",
      "author": "E Rennel",
      "doi-asserted-by": "publisher",
      "first-page": "1250",
      "issue": "7",
      "journal-title": "Br J Cancer",
      "key": "545_CR52",
      "unstructured": "Rennel E, Waine E, Guan H, Schüler Y, Leenders W, Woolard J, et al. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice. Br J Cancer. 2008;98(7):1250–7.",
      "volume": "98",
      "year": "2008"
    },
    {
      "DOI": "10.1074/jbc.M209236200",
      "author": "DR Mercatante",
      "doi-asserted-by": "publisher",
      "first-page": "49374",
      "issue": "51",
      "journal-title": "J Biol Chem",
      "key": "545_CR53",
      "unstructured": "Mercatante DR, Mohler JL, Kole R. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. J Biol Chem. 2002;277(51):49374–82.",
      "volume": "277",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ebiom.2018.05.002",
      "author": "Y Gan",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "EBioMedicine",
      "key": "545_CR54",
      "unstructured": "Gan Y, Li Y, Long Z, Lee AR, Xie N, Lovnicki JM, et al. Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer. EBioMedicine. 2018;31:267–75.",
      "volume": "31",
      "year": "2018"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-2788",
      "author": "MP Paronetto",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "issue": "1",
      "journal-title": "Cancer Res",
      "key": "545_CR55",
      "unstructured": "Paronetto MP, Cappellari M, Busà R, Pedrotti S, Vitali R, Comstock C, et al. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Cancer Res. 2010;70(1):229–39.",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-3468",
      "author": "NA Olshavsky",
      "doi-asserted-by": "publisher",
      "first-page": "3975",
      "issue": "10",
      "journal-title": "Cancer Res",
      "key": "545_CR56",
      "unstructured": "Olshavsky NA, Comstock CE, Schiewer MJ, Augello MA, Hyslop T, Sette C, et al. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene. Cancer Res. 2010;70(10):3975–84.",
      "volume": "70",
      "year": "2010"
    },
    {
      "DOI": "10.1172/JCI64750",
      "author": "MA Augello",
      "doi-asserted-by": "publisher",
      "first-page": "493",
      "issue": "1",
      "journal-title": "J Clin Investig",
      "key": "545_CR57",
      "unstructured": "Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, et al. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes. J Clin Investig. 2013;123(1):493–508.",
      "volume": "123",
      "year": "2013"
    },
    {
      "author": "Z-G Huang",
      "first-page": "2473",
      "journal-title": "Int J Oncol",
      "key": "545_CR58",
      "unstructured": "Huang Z-G, He R-Q, Mo Z-N. Prognostic value and potential function of splicing events in prostate adenocarcinoma. Int J Oncol. 2018;53:2473.",
      "volume": "53",
      "year": "2018"
    },
    {
      "DOI": "10.1002/gcc.22364",
      "author": "L Latonen",
      "doi-asserted-by": "publisher",
      "first-page": "617",
      "issue": "8",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "545_CR59",
      "unstructured": "Latonen L, Leinonen KA, Grönlund T, Vessella RL, Tammela TL, Saramäki OR, et al. Amplification of the 9p13.3 chromosomal region in prostate cancer. Genes Chromosomes Cancer. 2016;55(8):617–25.",
      "volume": "55",
      "year": "2016"
    },
    {
      "DOI": "10.1080/004982598238868",
      "author": "G Smith",
      "doi-asserted-by": "publisher",
      "first-page": "1129",
      "issue": "12",
      "journal-title": "Xenobiotica",
      "key": "545_CR60",
      "unstructured": "Smith G, Stubbins MJ, Harries LW, Wolf CR. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica. 1998;28(12):1129–65.",
      "volume": "28",
      "year": "1998"
    },
    {
      "DOI": "10.3390/cancers12040989",
      "author": "P Gorjala",
      "doi-asserted-by": "publisher",
      "first-page": "989",
      "issue": "4",
      "journal-title": "Cancers (Basel).",
      "key": "545_CR61",
      "unstructured": "Gorjala P, Kittles RA, Goodman OB Jr, Mitra R. Role of CYP3A5 in modulating androgen receptor signaling and its relevance to African American men with prostate cancer. Cancers (Basel). 2020;12(4):989.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.canlet.2005.03.009",
      "author": "L Zhenhua",
      "doi-asserted-by": "publisher",
      "first-page": "237",
      "issue": "2",
      "journal-title": "Cancer Lett",
      "key": "545_CR62",
      "unstructured": "Zhenhua L, Tsuchiya N, Narita S, Inoue T, Horikawa Y, Kakinuma H, et al. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population. Cancer Lett. 2005;225(2):237–43.",
      "volume": "225",
      "year": "2005"
    },
    {
      "DOI": "10.3389/fgene.2020.00726",
      "author": "XY Shao",
      "doi-asserted-by": "publisher",
      "first-page": "726",
      "journal-title": "Front Genet",
      "key": "545_CR63",
      "unstructured": "Shao XY, Dong J, Zhang H, Wu YS, Zheng L. Prognostic value and potential role of alternative mRNA splicing events in cervical cancer. Front Genet. 2020;11:726.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12885-020-06784-7",
      "author": "K Mukund",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "545_CR64",
      "unstructured": "Mukund K, Syulyukina N, Ramamoorthy S, Subramaniam S. Right and left-sided colon cancers—specificity of molecular mechanisms in tumorigenesis and progression. BMC Cancer. 2020;20(1):317.",
      "volume": "20",
      "year": "2020"
    },
    {
      "DOI": "10.18632/aging.101902",
      "author": "P Lin",
      "doi-asserted-by": "publisher",
      "first-page": "2082",
      "issue": "7",
      "journal-title": "Aging (Albany NY)",
      "key": "545_CR65",
      "unstructured": "Lin P, He RQ, Huang ZG, Zhang R, Wu HY, Shi L, et al. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis. Aging (Albany NY). 2019;11(7):2082–97.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12885-021-08681-z",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "first-page": "958",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "545_CR66",
      "unstructured": "Li Y, Guo D. Genome-wide profiling of alternative splicing in glioblastoma and their clinical value. BMC Cancer. 2021;21(1):958.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1111/jcmm.15835",
      "author": "H Feng",
      "doi-asserted-by": "publisher",
      "first-page": "12667",
      "issue": "21",
      "journal-title": "J Cell Mol Med",
      "key": "545_CR67",
      "unstructured": "Feng H, Jin Z, Liu K, Peng Y, Jiang S, Wang C, et al. Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression. J Cell Mol Med. 2020;24(21):12667–80.",
      "volume": "24",
      "year": "2020"
    },
    {
      "DOI": "10.12659/MSM.925733",
      "author": "J Lu",
      "doi-asserted-by": "publisher",
      "journal-title": "Med Sci Monit",
      "key": "545_CR68",
      "unstructured": "Lu J, Wei S, Lou J, Yin S, Zhou L, Zhang W, et al. Systematic analysis of alternative splicing landscape in pancreatic adenocarcinoma reveals regulatory network associated with tumorigenesis and immune response. Med Sci Monit. 2020;26: e925733.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.bbrc.2006.12.229",
      "author": "K Suzuki-Utsunomiya",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "2",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "545_CR69",
      "unstructured": "Suzuki-Utsunomiya K, Hadano S, Otomo A, Kunita R, Mizumura H, Osuga H, et al. ALS2CL, a novel ALS2-interactor, modulates ALS2-mediated endosome dynamics. Biochem Biophys Res Commun. 2007;354(2):491–7.",
      "volume": "354",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ebiom.2018.09.021",
      "author": "Y Xiong",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "journal-title": "EBioMedicine",
      "key": "545_CR70",
      "unstructured": "Xiong Y, Deng Y, Wang K, Zhou H, Zheng X, Si L, et al. Profiles of alternative splicing in colorectal cancer and their clinical significance: a study based on large-scale sequencing data. EBioMedicine. 2018;36:183–95.",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.7150/jca.24569",
      "author": "J Liu",
      "doi-asserted-by": "publisher",
      "first-page": "1754",
      "issue": "10",
      "journal-title": "J Cancer",
      "key": "545_CR71",
      "unstructured": "Liu J, Li H, Shen S, Sun L, Yuan Y, Xing C. Alternative splicing events implicated in carcinogenesis and prognosis of colorectal cancer. J Cancer. 2018;9(10):1754–64.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.21037/atm-22-1531",
      "author": "S Ma",
      "doi-asserted-by": "publisher",
      "first-page": "479",
      "issue": "8",
      "journal-title": "Ann Transl Med",
      "key": "545_CR72",
      "unstructured": "Ma S, Zhu J, Wang M, Han T, Zhu J, Jiang R, et al. A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma. Ann Transl Med. 2022;10(8):479.",
      "volume": "10",
      "year": "2022"
    },
    {
      "author": "M Grzmil",
      "first-page": "97",
      "issue": "1",
      "journal-title": "Int J Oncol",
      "key": "545_CR73",
      "unstructured": "Grzmil M, Voigt S, Thelen P, Hemmerlein B, Helmke K, Burfeind P. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol. 2004;24(1):97–105.",
      "volume": "24",
      "year": "2004"
    },
    {
      "DOI": "10.1073/pnas.1802354115",
      "author": "JK Lee",
      "doi-asserted-by": "publisher",
      "first-page": "E4473",
      "issue": "19",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "545_CR74",
      "unstructured": "Lee JK, Bangayan NJ, Chai T, Smith BA, Pariva TE, Yun S, et al. Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer. Proc Natl Acad Sci USA. 2018;115(19):E4473–82.",
      "volume": "115",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13059-022-02789-6",
      "author": "JK David",
      "doi-asserted-by": "publisher",
      "first-page": "240",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "545_CR75",
      "unstructured": "David JK, Maden SK, Wood MA, Thompson RF, Nellore A. Retained introns in long RNA-seq reads are not reliably detected in sample-matched short reads. Genome Biol. 2022;23(1):240.",
      "volume": "23",
      "year": "2022"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-20-1943",
      "author": "G Monteuuis",
      "doi-asserted-by": "publisher",
      "first-page": "779",
      "issue": "4",
      "journal-title": "Cancer Res",
      "key": "545_CR76",
      "unstructured": "Monteuuis G, Schmitz U, Petrova V, Kearney PS, Rasko JEJ. Holding on to junk bonds: intron retention in cancer and therapy. Cancer Res. 2021;81(4):779–89.",
      "volume": "81",
      "year": "2021"
    },
    {
      "DOI": "10.2147/OTT.S149012",
      "author": "W Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "1683",
      "journal-title": "Onco Targets Ther",
      "key": "545_CR77",
      "unstructured": "Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, et al. Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer. Onco Targets Ther. 2018;11:1683–95.",
      "volume": "11",
      "year": "2018"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-09-0919",
      "author": "KK Waltering",
      "doi-asserted-by": "publisher",
      "first-page": "8141",
      "issue": "20",
      "journal-title": "Cancer Res",
      "key": "545_CR78",
      "unstructured": "Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Janne OA, et al. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res. 2009;69(20):8141–9.",
      "volume": "69",
      "year": "2009"
    },
    {
      "author": "G Zhou",
      "journal-title": "Med Sci Monit",
      "key": "545_CR79",
      "unstructured": "Zhou G, Shen M, Zhang Z. ZW10 binding factor (ZWINT), a direct target of Mir-204, predicts poor survival and promotes proliferation in breast cancer. Med Sci Monit. 2020;26: e921659.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.molcel.2020.10.019",
      "author": "NK Leclair",
      "doi-asserted-by": "publisher",
      "first-page": "648",
      "issue": "4",
      "journal-title": "Mol Cell",
      "key": "545_CR80",
      "unstructured": "Leclair NK, Brugiolo M, Urbanski L, Lawson SC, Thakar K, Yurieva M, et al. Poison exon splicing regulates a coordinated network of SR protein expression during differentiation and tumorigenesis. Mol Cell. 2020;80(4):648–65.",
      "volume": "80",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.bbagrm.2019.06.003",
      "author": "H Shenasa",
      "doi-asserted-by": "publisher",
      "issue": "11–12",
      "journal-title": "Biochim Biophys Acta Gene Regul Mech",
      "key": "545_CR81",
      "unstructured": "Shenasa H, Hertel KJ. Combinatorial regulation of alternative splicing. Biochim Biophys Acta Gene Regul Mech. 2019;1862(11–12): 194392.",
      "volume": "1862",
      "year": "2019"
    },
    {
      "DOI": "10.1073/pnas.1308610110",
      "author": "J Hu",
      "doi-asserted-by": "publisher",
      "first-page": "14520",
      "issue": "36",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "545_CR82",
      "unstructured": "Hu J, Ho AL, Yuan L, Hu B, Hua S, Hwang SS, et al. From the Cover: Neutralization of terminal differentiation in gliomagenesis. Proc Natl Acad Sci USA. 2013;110(36):14520–7.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.3892/or.2016.4732",
      "author": "S Dube",
      "doi-asserted-by": "publisher",
      "first-page": "3143",
      "issue": "6",
      "journal-title": "Oncol Rep",
      "key": "545_CR83",
      "unstructured": "Dube S, Thomas A, Abbott L, Benz P, Mitschow C, Dube DK, et al. Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines. Oncol Rep. 2016;35(6):3143–50.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1186/1471-2164-11-676",
      "author": "W Langer",
      "doi-asserted-by": "publisher",
      "first-page": "676",
      "journal-title": "BMC Genomics",
      "key": "545_CR84",
      "unstructured": "Langer W, Sohler F, Leder G, Beckmann G, Seidel H, Gröne J, et al. Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics. 2010;11:676.",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1074/mcp.M700590-MCP200",
      "author": "K Thorsen",
      "doi-asserted-by": "publisher",
      "first-page": "1214",
      "issue": "7",
      "journal-title": "Mol Cell Proteomics",
      "key": "545_CR85",
      "unstructured": "Thorsen K, Sørensen KD, Brems-Eskildsen AS, Modin C, Gaustadnes M, Hein AM, et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics. 2008;7(7):1214–24.",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1073/pnas.1424272112",
      "author": "P Jiang",
      "doi-asserted-by": "publisher",
      "first-page": "7731",
      "issue": "25",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "545_CR86",
      "unstructured": "Jiang P, Freedman ML, Liu JS, Liu XS. Inference of transcriptional regulation in cancers. Proc Natl Acad Sci USA. 2015;112(25):7731–6.",
      "volume": "112",
      "year": "2015"
    },
    {
      "DOI": "10.1016/0896-6273(93)90077-5",
      "author": "RJ Buckanovich",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "issue": "4",
      "journal-title": "Neuron",
      "key": "545_CR87",
      "unstructured": "Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron. 1993;11(4):657–72.",
      "volume": "11",
      "year": "1993"
    },
    {
      "DOI": "10.1038/nature05304",
      "author": "J Ule",
      "doi-asserted-by": "publisher",
      "first-page": "580",
      "issue": "7119",
      "journal-title": "Nature",
      "key": "545_CR88",
      "unstructured": "Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, et al. An RNA map predicting Nova-dependent splicing regulation. Nature. 2006;444(7119):580–6.",
      "volume": "444",
      "year": "2006"
    },
    {
      "DOI": "10.1038/ng1610",
      "author": "J Ule",
      "doi-asserted-by": "publisher",
      "first-page": "844",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "545_CR89",
      "unstructured": "Ule J, Ule A, Spencer J, Williams A, Hu JS, Cline M, et al. Nova regulates brain-specific splicing to shape the synapse. Nat Genet. 2005;37(8):844–52.",
      "volume": "37",
      "year": "2005"
    },
    {
      "DOI": "10.3389/fcell.2021.673873",
      "author": "T Zhang",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Cell Dev Biol",
      "key": "545_CR90",
      "unstructured": "Zhang T, Chen S, Peng Y, Wang C, Cheng X, Zhao R, et al. NOVA1-mediated SORBS2 isoform promotes colorectal cancer migration by activating the notch pathway. Front Cell Dev Biol. 2021;9: 673873.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.trsl.2022.07.005",
      "author": "S Pedraza-Arevalo",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "Transl Res",
      "key": "545_CR91",
      "unstructured": "Pedraza-Arevalo S, Alors-Pérez E, Blázquez-Encinas R, Herrera-Martínez AD, Jiménez-Vacas JM, Fuentes-Fayos AC, et al. Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Transl Res. 2023;251:63–73.",
      "volume": "251",
      "year": "2023"
    },
    {
      "DOI": "10.1186/s12885-022-10164-8",
      "author": "L Qu",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "545_CR92",
      "unstructured": "Qu L, Tian Y, Wang F, Li Z. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling. BMC Cancer. 2022;22(1):1091.",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1371/journal.pone.0184590",
      "author": "D Ready",
      "doi-asserted-by": "publisher",
      "issue": "9",
      "journal-title": "PLoS ONE",
      "key": "545_CR93",
      "unstructured": "Ready D, Yagiz K, Amin P, Yildiz Y, Funari V, Bozdag S, et al. Mapping the STK4/Hippo signaling network in prostate cancer cell. PLoS ONE. 2017;12(9): e0184590.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1541-7786.MCR-14-0366",
      "author": "ZX Lu",
      "doi-asserted-by": "publisher",
      "first-page": "305",
      "issue": "2",
      "journal-title": "Mol Cancer Res",
      "key": "545_CR94",
      "unstructured": "Lu ZX, Huang Q, Park JW, Shen S, Lin L, Tokheim CJ, et al. Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization. Mol Cancer Res. 2015;13(2):305–18.",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ebiom.2019.11.008",
      "author": "JM Jiménez-Vacas",
      "doi-asserted-by": "publisher",
      "journal-title": "EBioMedicine",
      "key": "545_CR95",
      "unstructured": "Jiménez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, Gómez-Gómez E, Fuentes-Fayos AC, León-González AJ, et al. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. 2020;51: 102547.",
      "volume": "51",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.1808696116",
      "author": "N Ripin",
      "doi-asserted-by": "publisher",
      "first-page": "2935",
      "issue": "8",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "545_CR96",
      "unstructured": "Ripin N, Boudet J, Duszczyk MM, Hinniger A, Faller M, Krepl M, et al. Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM. Proc Natl Acad Sci USA. 2019;116(8):2935–44.",
      "volume": "116",
      "year": "2019"
    },
    {
      "author": "V D'Alessandro",
      "first-page": "291",
      "issue": "4",
      "journal-title": "Cell Oncol",
      "key": "545_CR97",
      "unstructured": "D’Alessandro V, Muscarella LA, Copetti M, Zelante L, Carella M, Vendemiale G. Molecular detection of neuron-specific ELAV-like-positive cells in the peripheral blood of patients with small-cell lung cancer. Cell Oncol. 2008;30(4):291–7.",
      "volume": "30",
      "year": "2008"
    },
    {
      "DOI": "10.1002/cbf.1468",
      "author": "YY Wu",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "4",
      "journal-title": "Cell Biochem Funct",
      "key": "545_CR98",
      "unstructured": "Wu YY, Li H, Lv XY, Wei Q, Li X, Liu XY, et al. Overexpression of JKTBP1 induces androgen-independent LNCaP cell proliferation through activation of epidermal growth factor-receptor (EGF-R). Cell Biochem Funct. 2008;26(4):467–77.",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.gene.2018.11.026",
      "author": "RZ Li",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Gene",
      "key": "545_CR99",
      "unstructured": "Li RZ, Hou J, Wei Y, Luo X, Ye Y, Zhang Y. hnRNPDL extensively regulates transcription and alternative splicing. Gene. 2019;687:125–34.",
      "volume": "687",
      "year": "2019"
    },
    {
      "DOI": "10.1371/journal.pone.0186047",
      "author": "C Arthurs",
      "doi-asserted-by": "publisher",
      "issue": "10",
      "journal-title": "PLoS ONE",
      "key": "545_CR100",
      "unstructured": "Arthurs C, Murtaza BN, Thomson C, Dickens K, Henrique R, Patel HRH, et al. Expression of ribosomal proteins in normal and cancerous human prostate tissue. PLoS ONE. 2017;12(10): e0186047.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.7554/eLife.47678",
      "author": "J Munkley",
      "doi-asserted-by": "publisher",
      "first-page": "e47678",
      "journal-title": "Elife",
      "key": "545_CR101",
      "unstructured": "Munkley J, Li L, Krishnan SRG, Hysenaj G, Scott E, Dalgliesh C, et al. Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer. Elife. 2019;8:e47678.",
      "volume": "8",
      "year": "2019"
    },
    {
      "DOI": "10.1261/rna.070318.119",
      "author": "A Brumwell",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "issue": "3",
      "journal-title": "RNA",
      "key": "545_CR102",
      "unstructured": "Brumwell A, Fell L, Obress L, Uniacke J. Hypoxia influences polysome distribution of human ribosomal protein S12 and alternative splicing of ribosomal protein mRNAs. RNA. 2020;26(3):361–71.",
      "volume": "26",
      "year": "2020"
    }
  ],
  "reference-count": 102,
  "references-count": 102,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00545-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}